MNDR is an AI-powered digital health company operating across Southeast Asia with proprietary AI technologies including Phi GPT engine and Aiko health intelligence companion. The company recently launched Otter.SG, an AI-powered SaaS clinic operating system with automated transcription and documentation support starting at US$50/month.
Cyborg Score Rationale
FY2025 revenue declined 45.26% to $7.65 million. Market cap as of April 13, 2026 was $2.94MM with stock trading at $0.85/share. However, H1 FY2026 showed improvement with gross margin expansion to 20.1% and net loss narrowing 48.2%.
Top Insights
H1 FY2026 achieved 25.3% higher gross profit, 29.9% lower operating expenses, and narrowed net loss 48.2% to $0.86M with cash at $3.48M
Acquired AI data center assets in Malaysia (PP Grid) in March 2026 targeting $127M capital injection to develop AI infrastructure and healthcare platform services
Signed strategic partnership MOU with Medpod in March 2026 to integrate AI platform with telediagnostics for deployment across Southeast Asia and Africa
Operates diversified platforms including MaNaPharma for pharmaceutical wholesale, MaNaCare for corporate healthcare, and online e-commerce for wellness products
Named Competitors
Telemedicine Platforms — Competing virtual care services in Southeast Asia
Health Tech Platforms — AI-powered healthcare ecosystem providers
Recent Developments
(April 2026) Net loss improvement with enhanced gross margins and cost optimization in H1 FY2026
(March 2026) Definitive agreement to acquire PP Grid Sdn. Bhd. AI data centers in Malaysia
(March 2026) Strategic partnership MOU with Medpod for global healthcare expansion
(February 2026) Launched Otter.SG AI-powered clinic operating system with global availability
Open the full interactive Mobile-health Network Solutions report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.